Suppr超能文献

ATP柠檬酸裂解酶的表达与胃腺癌的晚期阶段及预后相关。

ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma.

作者信息

Qian Xuchen, Hu Jiangfeng, Zhao Jiyi, Chen Hong

机构信息

Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University Nanjing, China.

Department of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai, China.

出版信息

Int J Clin Exp Med. 2015 May 15;8(5):7855-60. eCollection 2015.

Abstract

Gastric adenocarcinoma (GA) is one of the most common cancer worldwide. ATP citrate lyase (ACLY) is generally recognized as a key enzyme of de novo fatty acid synthesis responsible for generation of oxaloacetate and cytosolic acetyl-CoA. This study aimed to investigate the expression level of ACLY in GA and evaluate the relationship between ACLY expression and the prognosis of GA patients. Paraffin archived samples from 83 GA patients were used to analyze ACLY expression by immunohistochemistry. ACLY was significantly upregulated in GA tissues compared with adjacent normal tissues (P < 0.001). High ACLY expression was correlated with advanced stages (P = 0.007) and lymph node metastasis (P = 0.022). Furthermore, patients with low ACLY expression had longer survival time than those with high ACLY expression (P = 0.031). In conclusion, these results indicate that ACLY might serve as a biomarker to predict the progression and prognosis of GA patients.

摘要

胃腺癌(GA)是全球最常见的癌症之一。ATP柠檬酸裂解酶(ACLY)通常被认为是从头脂肪酸合成的关键酶,负责生成草酰乙酸和胞质乙酰辅酶A。本研究旨在调查ACLY在GA中的表达水平,并评估ACLY表达与GA患者预后之间的关系。采用免疫组织化学方法分析83例GA患者石蜡存档样本中ACLY的表达。与相邻正常组织相比,GA组织中ACLY明显上调(P < 0.001)。ACLY高表达与晚期(P = 0.007)和淋巴结转移(P = 0.022)相关。此外,ACLY低表达患者的生存时间比ACLY高表达患者长(P = 0.031)。总之,这些结果表明ACLY可能作为预测GA患者病情进展和预后的生物标志物。

相似文献

2
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
Cancer Res. 2008 Oct 15;68(20):8547-54. doi: 10.1158/0008-5472.CAN-08-1235.
3
Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer.
Med Oncol. 2015 Mar;32(3):85. doi: 10.1007/s12032-015-0540-z. Epub 2015 Feb 21.
4
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Eur J Med Chem. 2018 Sep 5;157:1276-1291. doi: 10.1016/j.ejmech.2018.09.001. Epub 2018 Sep 1.
6
ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
FEBS J. 2015 Jan;282(2):361-71. doi: 10.1111/febs.13139. Epub 2014 Nov 23.
7
ATP-citrate lyase deficiency in the mouse.
J Biol Chem. 2004 Mar 5;279(10):9557-64. doi: 10.1074/jbc.M310512200. Epub 2003 Dec 8.
8
ATP citrate lyase: A central metabolic enzyme in cancer.
Cancer Lett. 2020 Feb 28;471:125-134. doi: 10.1016/j.canlet.2019.12.010. Epub 2019 Dec 9.
9
Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly.
PLoS One. 2015 May 11;10(5):e0126357. doi: 10.1371/journal.pone.0126357. eCollection 2015.

引用本文的文献

1
Lipid metabolism-related genes in gastric cancer: Exploring oncogenic pathways.
World J Gastrointest Oncol. 2025 Aug 15;17(8):106842. doi: 10.4251/wjgo.v17.i8.106842.
2
Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.
Int J Mol Sci. 2024 Oct 22;25(21):11371. doi: 10.3390/ijms252111371.
3
The pathological significance and potential mechanism of ACLY in cholangiocarcinoma.
Front Immunol. 2024 Sep 27;15:1477267. doi: 10.3389/fimmu.2024.1477267. eCollection 2024.
5
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers.
Front Pharmacol. 2024 Jun 27;15:1367981. doi: 10.3389/fphar.2024.1367981. eCollection 2024.
6
Immunometabolism in cancer: basic mechanisms and new targeting strategy.
Cell Death Discov. 2024 May 16;10(1):236. doi: 10.1038/s41420-024-02006-2.
8
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy.
Mol Cell Biochem. 2025 Jan;480(1):103-118. doi: 10.1007/s11010-024-04995-1. Epub 2024 Apr 15.
10
Metabolic basis of cardiac dysfunction in cancer patients.
Curr Opin Cardiol. 2024 May 1;39(3):138-147. doi: 10.1097/HCO.0000000000001118. Epub 2024 Feb 21.

本文引用的文献

1
ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Curr Drug Targets. 2015;16(2):156-63. doi: 10.2174/1389450115666141224125117.
2
Targeting mitochondrial citrate transport in breast cancer cell lines.
Anticancer Agents Med Chem. 2015;15(3):374-81. doi: 10.2174/1871520615666141216150659.
3
Tracking down the origin of cancer: metabolic reprogramming as a driver of stemness and tumorigenesis.
Crit Rev Oncog. 2014;19(5):363-82. doi: 10.1615/critrevoncog.2014011844.
4
Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth.
Cancer Lett. 2014 Jul 10;349(1):15-25. doi: 10.1016/j.canlet.2014.03.015. Epub 2014 Mar 29.
5
Androgen-regulated metabolism and biosynthesis in prostate cancer.
Endocr Relat Cancer. 2014 Aug;21(4):T57-66. doi: 10.1530/ERC-13-0515. Epub 2014 Feb 4.
6
7
Targeting metabolic changes in cancer: novel therapeutic approaches.
Annu Rev Med. 2014;65:157-70. doi: 10.1146/annurev-med-092012-112344.
8
Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
Int J Cancer. 2014 Jul 1;135(1):37-47. doi: 10.1002/ijc.28652. Epub 2013 Dec 18.
9
Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Pathol Res Pract. 2013 Aug;209(8):510-5. doi: 10.1016/j.prp.2013.06.005. Epub 2013 Jun 28.
10
Cancer statistics, 2013.
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验